CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing innovative tools and methods to prevent complications associated with diabetes mellitus. By leveraging expertise in genetics, biomarker discovery, and advanced imaging techniques, the initiative aims to identify and validate new markers for vascular complications, ultimately improving…
Diabetes mellitus is a lifelong, incapacitating disease affecting multiple organs.
Worldwide prevalence figures estimate that there will be 246 million diabetic patients in 2007 and 380 million in 2025.
Presently, diabetes can neither be prevented nor cured and the disease is associated with devastating chronic complications including coronary heart disease and stroke (macrovascular disease) as well as microvascular disorders leading to damage of the small blood vessels of the kidney (nephropath…
BOEHRINGER INGELHEIM INTERNATIONALGMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Lund
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Finland, Espoo
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
